Hepatitis C: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (→Notable studies: format) |
Notjusttired (talk | contribs) m (format) |
||
| Line 20: | Line 20: | ||
*[https://en.wikipedia.org/wiki/Hepatitis_C Wikipedia - Hepatitis C] | *[https://en.wikipedia.org/wiki/Hepatitis_C Wikipedia - Hepatitis C] | ||
== | Hepatitis C is considered a global health problem <ref name="GBD204">{{citation|last1=GBD 2013 Mortality and Causes of Death|first1=Collaborators|title=Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.|journal=Lancet|date=17 December 2014|pmid=25530442|doi=10.1016/S0140-6736(14)61682-2|volume=385|issue=9963|pages=117–71|pmc=4340604}}</ref> | ||
<ref name="Siu2016">{{citation | |||
==See also== | |||
==Learn more== | |||
*2016, [http://www.nature.com/articles/srep23464 Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation]<ref name="Siu2016">{{citation | |||
| last1 = Siu | first1 = Gavin Ka Yu | authorlink1 = | | last1 = Siu | first1 = Gavin Ka Yu | authorlink1 = | ||
| last2 = Zhou | first2 = Fan | authorlink2 = | | last2 = Zhou | first2 = Fan | authorlink2 = | ||
| Line 36: | Line 40: | ||
| url = http://www.nature.com/articles/srep23464 | | url = http://www.nature.com/articles/srep23464 | ||
}}</ref> | }}</ref> | ||
<ref name="WHO2015">{{citation|title=Hepatitis C Fact sheet N°164|url=http://www.who.int/mediacentre/factsheets/fs164/en/|website=WHO|accessdate=4 February 2016|date=July 2015}}</ref> | *[http://www.who.int/mediacentre/factsheets/fs164/en/ Factsheet]<ref name="WHO2015">{{citation|title=Hepatitis C Fact sheet N°164|url=http://www.who.int/mediacentre/factsheets/fs164/en/|website=WHO|accessdate=4 February 2016|date=July 2015}}</ref> - World Health Organization | ||
==References== | |||
{{Reflist}} | |||
[[Category:Triggers and risk factors]] | [[Category:Triggers and risk factors]] | ||
Revision as of 22:35, July 31, 2020
Hepatitis C (HCV or Hep C) is a disease caused by an RNA virus that affects approximately 170 million people worldwide[1] and is most often known for its associations with liver damage.
Hepatitis C incidence has been shown to be increased in chronic fatigue syndrome patients.
Prevalence[edit | edit source]
It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.[2] In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.[3]
Transmission[edit | edit source]
Signs and symptoms[edit | edit source]
Diagnosis[edit | edit source]
Hepatitis C in Chronic Fatigue Syndrome[edit | edit source]
Notable studies[edit | edit source]
Potential treatments[edit | edit source]
Learn more[edit | edit source]
Hepatitis C is considered a global health problem [3]
See also[edit | edit source]
Learn more[edit | edit source]
- 2016, Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation[1]
- Factsheet[2] - World Health Organization
References[edit | edit source]
- ↑ 1.0 1.1 Siu, Gavin Ka Yu; Zhou, Fan; Yu, Mei Kuen; Zhang, Leiliang; Wang, Tuanlao; Liang, Yongheng; Chen, Yangchao; Chan, Hsiao Chang; Yu, Sidney (2016), "Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation", Scientific Reports 6, doi:10.1038/srep23464 Cite has empty unknown parameter:
|1=(help) - ↑ 2.0 2.1 "Hepatitis C Fact sheet N°164", WHO, July 2015, retrieved February 4, 2016
- ↑ 3.0 3.1 GBD 2013 Mortality and Causes of Death, Collaborators (December 17, 2014), "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.", Lancet, 385 (9963): 117–71, doi:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442
